FreeStyle Libre Plus Bluetooth Transmitter Adjunct: Can This Improve Glucose Accuracy and Reduce Burden of Hypoglycaemia
NCT04147637 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-02-10
Summary
Advanced glucose monitoring systems have revolutionized diabetes care and enabled people with diabetes to achieve better diabetes control with reduced risk of hypoglycaemia. Continuous glucose monitoring (CGM) systems provide real-time glucose monitoring and alarms when glucose approaches extreme readings (hypoglycaemia and hyperglycaemia) or when the change in glucose is rapid. All available CGM systems, except Dexcom G6, require daily calibrations with capillary glucose readings in order to attain accuracy of glucose readings. Decom G6 system is not widely accessible and only available in certain countries. Flash glucose monitoring systems (Flash) provide glucose readings when users actively scan their sensors. FreeStyle Libre (FSL) is the only Flash glucose monitoring system currently available in market. FSL is factory calibrated and sensors are ready to use after placement and initiation. The two main differences between Flash and CGM are user interaction and the alarm facility. While CGM provide real-time glucose readings, Flash is user-dependent for actively scanning and understanding the readings. Moreover, CGM systems provide alarms for low or high glucose and for rapid glucose changes, while Flash does not routinely provide alarms. This is particularly relevant when patients have impaired or lost hypoglycaemia awareness. CGM systems are costlier compared to Flash, which has contributed to the wider adoption of FSL.
Several Bluetooth adjuncts have been introduced to market for FSL. These devices attach to Libre sensor and connect to the user's mobile phone via Bluetooth. This enables continuous and real-time feed of glucose readings from the sensor to patient's mobile phone, which enables a wide range of customizable alarms for high and low glucose levels and for rapid glucose changes. This setup also enables calibration of Libre sensor with capillary glucose which, anecdotally, has been reported to improve sensor accuracy. None of these adjuncts have been validated clinically. FSL with Bluetooth adjunct such as MiaoMiao remain cheaper than current CGM options and could be more accessible in some countries than CGM. However, without robust evidence to support effectiveness and safety of such setup it is not possible to recommend this.
The Objective of this study is to determine whether FSL with Bluetooth Adjunct is superior to FSL alone in accuracy and reduction of hypoglycaemia burden.
Conditions
- Type1 Diabetes Mellitus
Interventions
- COMBINATION_PRODUCT
-
FreeStyle Libre with MiaoMiao
Use of FreeStyle Libre with MiaoMiao Bluetooth adjunct and mobile device application to enable calibration and alarms
- DEVICE
-
FreeStyle Libre alone
Use of standard FreeStyle Libre with Libre Link app and mobile phone scanning
Sponsors & Collaborators
-
Dasman Diabetes Institute
lead OTHER
Principal Investigators
-
Ali Aldibbiat, MD PhD FRCP · Dasman Diabetes Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-14
- Primary Completion
- 2021-04-30
- Completion
- 2021-08-31
Countries
- Kuwait
Study Locations
More Related Trials
-
Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)
NCT05257460 ·Status: COMPLETED ·Phase: NA
-
A Study of LY900014 in a Medtronic Pump
NCT03760640 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia
NCT02657213 ·Status: COMPLETED ·Phase: NA
-
Four Way Crossover Closed Loop With Exercise Detection
NCT02862730 ·Status: COMPLETED ·Phase: NA
-
Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System
NCT01148862 ·Status: COMPLETED ·Phase: NA
-
Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes
NCT01713348 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Patients With Type 1 Diabetes Mellitus
NCT00447213 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
NCT04667182 ·Status: WITHDRAWN
-
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
NCT02081014 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
NCT02846831 ·Status: COMPLETED ·Phase: PHASE2
-
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
NCT06668935 ·Status: RECRUITING
-
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02465411 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Minimed 670G in T1D Patients on Multiple Daily Injection
NCT03755479 ·Status: COMPLETED
-
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
NCT01769404 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
NCT03056456 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens
NCT05036343 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
NCT02656069 ·Status: COMPLETED ·Phase: PHASE3
-
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
NCT03349489 ·Status: UNKNOWN ·Phase: NA
-
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
NCT01666028 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin
NCT04533945 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI
NCT03017287 ·Status: TERMINATED ·Phase: NA
-
Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus
NCT01185496 ·Status: COMPLETED